The anti-obesity drug, V24343, acts by targeting the CB1 receptor in the brain and suppressing a person's appetite.
The anti-obesity drug, V24343, acts by targeting the CB1 receptor in the brain and suppressing a person's appetite.
Obesity related disorders such as cardiovascular disease and type II diabetes
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.